Table IV.

Association between UBE2T expression and the clinicopathological characteristics of patients with gallbladder cancer (n=127).

		UBE2T expression
Characteristic	Cases, n (%)	Low (n=32)	High (n=95)	P-value
Age, years
<50	4 (3.1)	0	4	0.238
≥50	123 (96.9)	32	91
Sex
Male	40 (31.5)	9	31	0.635
Female	87 (68.5)	23	64
Clinical stage
I	2 (1.6)	2	0	<0.001b
II	87 (68.5)	30	57
III	23 (18.1)	0	23
V	15 (11.8)	0	15
T classification
T1	2 (1.6)	2	0	<0.001b
T2	88 (69.3)	30	58
T3	32 (25.2)	0	32
T4	5 (3.9)	0	5
N classification
N0	91 (71.7)	32	59	<0.001b
N1	28 (22.0)	0	28
N2	8 (6.3)	0	8
M classification
M0	113 (89.0)	32	81	0.021a
M1	14 (11.0)	0	14
Histologic grade
I	24 (18.9)	9	15	0.3
II	60 (47.2)	13	47
III	43 (33.9)	10	33

^aP<0.05

^bP<0.001. UBE2T, ubiquitin conjugating enzyme E2T.